SCHEMBL25607261

SCHEMBL25607261

CCC1(CC)c2ccccc2-c2c1c1c(c3cc(N4CCOCC4)ccc23)OC(c2ccc(OC)cc2)(c2ccc(-c3ccccc3)cc2)C=C1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 3/20 0.35
MMP2 P08253 2/20 0.35
MMP3 P08254 2/20 0.35
MMP13 P45452 2/20 0.35
MMP1 P03956 1/20 0.35
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
AKT1 P31749 1/20 0.34
ATM Q13315 1/20 0.34
HTR1A P08908 1/20 0.33
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
TP53 P04637 1/20 0.33
TSHR P16473 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25606852 0.96 MAPT (0.34) PRKDCMEN1KMT2AAKT1ATM
SCHEMBL25600438 0.96 RAB9A (0.35) PRKDCMEN1KMT2AAKT1ATM
SCHEMBL25600434 0.96 RAB9A (0.35) PRKDCMEN1KMT2AAKT1ATM
SCHEMBL25607263 0.95 AKT1 (0.35) PRKDCMMP2MMP3MMP13MMP1
SCHEMBL25600439 0.95 PDK2 (0.33) KDM4EALDH1A1TDP1LMNAMAPT
SCHEMBL25600300 0.93 RAB9A (0.35) PRKDCKMT2AATMKDM4EALDH1A1
SCHEMBL25600428 0.93 PRKDC (0.35) PRKDCMMP2MMP3MMP13MMP1
SCHEMBL25844662 0.93 ADAM17 (0.34) KMT2AATMKDM4EALDH1A1TP53
SCHEMBL25844668 0.93 ADAM17 (0.35) PRKDCMEN1KMT2AATMKDM4E
SCHEMBL26627990 0.93 RAB9A (0.36) PRKDCKMT2AAKT1HTR1AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230340318-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES HOYA LENS THAILAND LTD. (TH) 2023-10-26 US disclosed
US-20230340318-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES HOYA LENS THAILAND LTD. (TH) 2023-10-26 US disclosed
US-20230227717-A1 PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND SPECTACLES HOYA LENS THAILAND LTD. (TH) 2023-07-20 US disclosed
US-20230227717-A1 PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND SPECTACLES HOYA LENS THAILAND LTD. (TH) 2023-07-20 US disclosed
EP-4198102-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES Hoya Lens Thailand Ltd. (TH) 2023-06-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230340318-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES NR2E3, CRY1, RPS10 PRKDC 4850/4885MMP2 4836/4885MMP3 4716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.